Home/ Stacks/ AOD-9604 + CJC-1295 (No DAC)

AOD-9604 + CJC-1295 (No DAC) Stack

Enhanced fat loss with GH-driven body recomposition.

Synergy Mechanism

Fat loss + GH optimization. AOD-9604 targets lipolysis while CJC-1295 elevates GH for body composition.

AOD-9604 (modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects.) and CJC-1295 (No DAC) (short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.) work through complementary pathways, producing a synergistic effect greater than either compound alone.

Combined Dosing Protocol

Compound	Dose	Frequency	WADA
AOD-9604	300mcg - 500mcg	Daily (fasted)	Not Listed
CJC-1295 (No DAC)	100mcg - 200mcg	2-3x daily (with Ipamorelin)	WADA Banned

Get This Protocol

Hatter Labs provides physician-supervised AOD-9604 + CJC-1295 (No DAC) stack protocols with GMP-certified compounds.

Get Protocol

Physician-Supervised Performance

Start Your Performance Protocol for AOD-9604 + CJC-1295 (No DAC) Stack

Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised